BECN1 antibody

Ref. 3D-10R-3435

Produktinformation

• Name: BECN1 antibody
• Marke: Biosynth
• Beschreibung: The BECN1 antibody is a highly potent cytotoxic agent that targets epidermal growth factor (EGF) receptors. It is an anti-CD33 antibody that specifically binds to CD33, a transmembrane protein expressed on myeloid cells. This monoclonal antibody can be used in various life science applications, including research and diagnostics. The BECN1 antibody can be conjugated with cytotoxic agents to create cytotoxic conjugates for targeted cancer therapy. It has been extensively studied and proven to be effective in inhibiting the growth of cancer cells in preclinical models. Additionally, this antibody exhibits excellent binding specificity and minimal cross-reactivity with other proteins present in human serum. The glycosylation of the BECN1 antibody ensures stability and enhances its therapeutic potential. Overall, the BECN1 antibody is a valuable tool for researchers and clinicians working in the field of oncology and immunotherapy.